TickerStat.com

Lakewood-Amedex Biotherapeutics Inc. (LABT)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

2 annual periodsNewest to oldest
20252024
Revenue$1.3M$2.1M
Research & development$1.3M$2.1M
Operating income−$3.8M−$4.0M
Net income−$3.8M−$4.9M
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.
Review ownership filings at SEC.gov ↗